David Rimm, MD, PhD

Professor of Pathology and of Medicine (Medical Oncology); Director of Pathology Tissue Services; Director of Translational Pathology

Departments & Organizations

Pathology: Autopsy | Experimental Pathology Graduate Program | Pathology Research | Rimm Lab | Surgical Pathology | Tissue Services: Specialized Translational Services

Internal Medicine: Medical Oncology

SPORE in Skin Cancer

Yale Cancer Center: K12 Calabresi Immuno-Oncology Training Program (IOTP) | Signal Transduction | SPORE in Lung Cancer

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Molecular Medicine, Pharmacology, and Physiology

Yale Medicine

Office of Cooperative Research


David Rimm is a Professor in the Department of Pathology at the Yale University School of Medicine. He completed an MD-PhD at Johns Hopkins University Medical School followed by a Pathology Residency at Yale and a Cytopathology Fellowship at the Medical College of Virginia. He is board certified in Anatomic Pathology and Cytopathology. At Yale since 1994, Dr. Rimm is the Director of Yale Pathology Tissue Services and the Yale Tissue Microarray Facility. He is a member of the Executive Team in Pathology and serves as the Director of Translational Pathology. His lab group focuses on quantitative pathology using the AQUA® technology invented in his lab with projects related to predicting response to therapy or recurrence or metastasis in breast and lung cancer.The technology has also been used in a series of efforts related to biospecimen science. The work is supported by grants from the NIH, BCRF, and sponsored research agreements from biopharma. He is a member of a number of correlative science committees for multi-institutional breast cancer clinical trials including SWOG, ALLTO, and TEACH.He also serves on the Molecular Oncology committee for the College of American Pathologists (CAP).He is an author of over 300 peer-reviewed papers and 8 patents.He has served on advisory boards for Amgen, Genentech, Novartis, BMS, Perkin Elmer, Dako, ACD, Biocept, OptraScan and Genoptix.He was a scientific co-founder of HistoRx, a digital pathology company (sold to Genoptix in 2012) and Metamark Genetics, a prognostic determinant company.

Education & Training

MD Johns Hopkins University (1989)
PhD Johns Hopkins University (1989)
Fellow Medical College of Virginia
Resident Yale-New Haven Hospital
Board Certification AB of Pathology, Anatomic Pathology (1995)
Board Certification AB of Pathology, Cytopathology (1996)

Honors & Recognition

  • Lauren Ackerman LectureshipWashington University of St. Louis (2008)

  • StarwoodCommitment Award 2004Greenwich Breast Cancer Alliance (2004)

Edit this profile

Contact Info

David Rimm, MD, PhD
Patient Care Locations
Yale PathologyBrady Memorial Laboratory
310 Cedar Street, Ste BML 55

New Haven, CT 06510
View on map...
Yale PathologyYale New Haven Hospital
20 York Street, Ste East Pavilion 2-631

New Haven, CT 06510
View on map...
Office Location
Department of PathologyBrady Memorial Laboratory
310 Cedar Street, Ste BML 116A

New Haven, CT 06510
View on map...
Mailing Address
Pathology310 Cedar Street
PO Box 208023

New Haven, CT 06520-8023

Rimm Lab